Lecture by Dr. David Dingli, MD, at the Mayo Clinic on Dyamic Aspects of Hematopoiesis and Its Disorders.
David Dingli, MD, PhD, is a Professor of Medicine at Mayo Clinic with joint appointments in the
Division of Hematology, Department of Internal Medicine, and the Department of Molecular
Medicine. He is also an Adjunct Professor in the Biomedical Informatics and Computational
Biology Program at the University of Minnesota Rochester. He received his MD degree from the
University of Malta in 1992 and his PhD in molecular biology from the Mayo Graduate School in
2003. He trained in internal medicine in Malta and at Mayo Clinic and received his training in
hematology at the University of Glasgow Hospitals (United Kingdom) and Mayo Clinic. After he
fi nished his clinical training, Dr. Dingli was a Mayo Clinic Scholar and Visiting Scientist at the
Harvard University Program for Evolutionary Dynamics, from 2005 to 2007.
Dr. Dingli returned to Mayo Clinic in July 2007 to establish his practice in hematology and
his independent research program. His research bridges the interface between medicine and
mathematics and focuses on the dynamics of tumor growth and evolution, with the aim of
understanding the disease and optimizing its therapy. In his research, Dr. Dingli combines
mathematical and computational models to understand the origin and evolution of hematologic
disorders and their therapy. He has applied various mathematical approaches to the fi eld,
including deterministic and stochastic models as well as evolutionary game theory, to understand
how the tumors interacts with normal cells, leading to different phenotypic manifestations of
disease.
Dr. Dingli is the recipient of numerous awards, including the Bellman Prize in Mathematical
Bioscience. He is the author or coauthor of over 200 research articles, several book chapters, and
over 200 abstracts. His research is funded by the National Institutes of Health, Industry, and Mayo
Clinic. He has been a Visiting Professor at various institutions, including Harvard, Princeton,
and Stanford universities; the University of California; the University of Minnesota; and the Max
Planck Institute for Evolutionary Biology.